SDS Biotech K.K. reported consolidated earnings results for the nine months ended September 30, 2015. For the period, the company reported net sales of ¥10,864 million against ¥10,011 million a year ago. Operating income was ¥630 million against ¥555 million a year ago. Ordinary income was ¥380 million against ¥409 million a year ago. Net income was ¥299 million or ¥38.23 per basic and diluted share against ¥220 million or ¥28.19 per basic and diluted share a year ago. Net income before taxes was ¥381,611,000 against ¥402,273,000 a year ago.

The company provided consolidated earnings guidance for the fiscal year ending March 31, 2016. For the year, the company expects to report net sales of ¥20,880 million, operating income of ¥2,170 million, ordinary income of ¥1,800 million and net income of ¥1,100 million or ¥140.46 per share.

The company provided dividend guidance for the year ended March 31, 2016. For the year the company expects to pay dividend of ¥15.00 as compared to ¥10.00 last year.

In line with the change of fiscal year-end (last day of a fiscal year) from December 31 to March 31, the fiscal year under review consists of 15 months from January 1, 2015 to March 31, 2016.